VectorY Therapeutics, a leader in vectorized antibody therapies for neurodegenerative diseases, announced today that the U.S.

SpliceBio, a clinical-stage genetic medicines company pioneering protein splicing to address diseases caused by mutations in large genes, today announced that the first patient has been dosed in the ...

Medera Inc. ("Medera"), a clinical-stage biopharmaceutical company focused on targeting cardiovascular diseases by developing next-generation therapeutics, today announced that the final patient has ...

Dosed First Patient in REVEAL Pivotal Trial in the Fourth Quarter of 2025. Additional enrollment continues to advance across ...

Cybersecurity experts discuss 2026 predictions, highlighting the rise of AI-driven threats and the need for advanced security ...

A visit to the Falkland Islands, where the fearless seabirds navigate the rugged topography with tenacious spunk, shows the ...

Medera has completed patient dosing in Cohort B of its ongoing MUSIC-HFpEF Phase I/IIa study of SRD-002 for heart failure ...

Company Achieves Clinical Development Milestones in 2025, Advances Program for Future Scale Up and Studies AUSTIN, Texas, Jan. 7, 2026 /PRNewswire/ -- Genprex, Inc.

First patient dosed in REVEAL pivotal trial evaluating TSHA-102 (N=15, aged 6 to Reached written alignment with FDA on inclusion of =3 months of safety data from ASPIRE trial evaluating TSHA-102 (N=3 ...

Social media influencer Hope Walz posted video of her family, including Democratic Gov. Tim Walz of Minnesota, eating fast ...

On Jan. 7, 2026, popular fast-food restaurant Dave's Hot Chicken took to their Instagram page to announce the limited-edition ...

A central Ohio-based fast-casual eatery serving Mediterranean and Middle Eastern food recently opened at Easton Town Center. ...